Rishon LeZiyyon, Israel

Nurit Rachamim

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Rishon LeZiyyon, IL (2018)
  • Rishon LeTzion, IL (2018)

Company Filing History:


Years Active: 2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Nurit Rachamim

Introduction

Nurit Rachamim is a prominent inventor based in Rishon LeZiyyon, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies and immune therapies. With a total of 2 patents, her work has the potential to impact various medical treatments.

Latest Patents

One of her latest patents involves humanized antibodies to cluster of differentiation 3 (CD3). These humanized monoclonal antibodies (mAbs) or fragments thereof confer improved immune stimulation and stability. The patent also discloses pharmaceutical compositions comprising these mAbs and methods for treating and preventing diseases and disorders, such as autoimmune disorders, infectious diseases, and transplant rejection, that can be ameliorated by binding to CD3. Another significant patent focuses on novel antibodies, methods, and compositions for treating diseases susceptible to amelioration by blocking APP cleavage, which is particularly relevant for dementia treatment.

Career Highlights

Throughout her career, Nurit has worked with notable companies, including Therapix Biosciences Ltd. and Ramot at Tel Aviv University Ltd. Her innovative approaches and research have positioned her as a key figure in her field.

Collaborations

Nurit has collaborated with esteemed colleagues, including Ronald Ellis and Michael Tal, contributing to the advancement of her research and the development of her patents.

Conclusion

Nurit Rachamim's contributions to biotechnology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…